Cargando…
Cardiac Contractility Modulation: A Technical Review
Therapeutic options for the management of systolic congestive heart failure involving newer implantable device technologies that were not previously available now exist. Cardiac contractility modulation (CCM) has been shown to benefit patients with class III systolic heart failure with an ejection f...
Autor principal: | Hesselson, Aaron B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MediaSphere Medical
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635574/ https://www.ncbi.nlm.nih.gov/pubmed/36605294 http://dx.doi.org/10.19102/icrm.2022.13102 |
Ejemplares similares
-
Normalization of ventricular function after cardiac contractility modulation in noncompaction cardiomyopathy heterozygous positive for a pathologic TTN gene variant
por: Hesselson, Aaron B., et al.
Publicado: (2022) -
Cardiac contractility modulation therapy: Are there superresponders?
por: Al-Ghamdi, Bandar, et al.
Publicado: (2017) -
Recent Insights in the Paracrine Modulation of Cardiomyocyte Contractility by Cardiac Endothelial Cells
por: Noireaud, Jacques, et al.
Publicado: (2014) -
Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond
por: Tschöpe, Carsten, et al.
Publicado: (2018) -
Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Mando, Ramy, et al.
Publicado: (2019)